Skip to content
Order

Whitepapers

What the published work shows

Two technical reviews of self-delivering antisense oligonucleotides, in cancer immunology and in neuroscience, and two close readings, each of one published study. We print no figure in them that a published study did not report.

  • Whitepaper

    AUMsilence sdASO in cancer and immunology research

    Published applications in cancer biology and immunology

    Domain:
    Cancer and immunology
    References:
    11
    Read the whitepaper

  • Whitepaper

    AUMsilence sdASO platform in neuroscience and neurodegeneration research

    Published applications in neurobiology and neurodegenerative disease

    Domain:
    Neuroscience and neurodegeneration
    References:
    8
    Read the whitepaper

  • Whitepaper

    Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity

    Transfection-free gene silencing in primary human T cells, from methodology to clinical samples

    Journal:
    Frontiers in Immunology
    Year:
    2024
    Product used:
    AUMsilence sdASO
    Read the whitepaper

  • Whitepaper

    TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease

    Loss-of-function validation of a tau quality control factor in primary cortical neurons

    Journal:
    Science
    Year:
    2023
    Product used:
    AUMsilence sdASO
    Read the whitepaper

For research use only. Not for use in diagnostic or therapeutic procedures.